Fluorine in PDB 6no8: PIM1 in Complex with CPD9 ((R)-5-Amino-N-(3-(4-Aminoazepan-1-Yl)-1H- Pyrazol-4-Yl)-2-(2,6-Difluorophenyl)Thiazole-4-Carboxamide)

Enzymatic activity of PIM1 in Complex with CPD9 ((R)-5-Amino-N-(3-(4-Aminoazepan-1-Yl)-1H- Pyrazol-4-Yl)-2-(2,6-Difluorophenyl)Thiazole-4-Carboxamide)

All present enzymatic activity of PIM1 in Complex with CPD9 ((R)-5-Amino-N-(3-(4-Aminoazepan-1-Yl)-1H- Pyrazol-4-Yl)-2-(2,6-Difluorophenyl)Thiazole-4-Carboxamide):
2.7.11.1;

Protein crystallography data

The structure of PIM1 in Complex with CPD9 ((R)-5-Amino-N-(3-(4-Aminoazepan-1-Yl)-1H- Pyrazol-4-Yl)-2-(2,6-Difluorophenyl)Thiazole-4-Carboxamide), PDB code: 6no8 was solved by J.M.Murray, X.Wang, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 37.09 / 2.38
Space group P 65
Cell size a, b, c (Å), α, β, γ (°) 96.452, 96.452, 80.655, 90.00, 90.00, 120.00
R / Rfree (%) 18.5 / 23.2

Fluorine Binding Sites:

The binding sites of Fluorine atom in the PIM1 in Complex with CPD9 ((R)-5-Amino-N-(3-(4-Aminoazepan-1-Yl)-1H- Pyrazol-4-Yl)-2-(2,6-Difluorophenyl)Thiazole-4-Carboxamide) (pdb code 6no8). This binding sites where shown within 5.0 Angstroms radius around Fluorine atom.
In total 2 binding sites of Fluorine where determined in the PIM1 in Complex with CPD9 ((R)-5-Amino-N-(3-(4-Aminoazepan-1-Yl)-1H- Pyrazol-4-Yl)-2-(2,6-Difluorophenyl)Thiazole-4-Carboxamide), PDB code: 6no8:
Jump to Fluorine binding site number: 1; 2;

Fluorine binding site 1 out of 2 in 6no8

Go back to Fluorine Binding Sites List in 6no8
Fluorine binding site 1 out of 2 in the PIM1 in Complex with CPD9 ((R)-5-Amino-N-(3-(4-Aminoazepan-1-Yl)-1H- Pyrazol-4-Yl)-2-(2,6-Difluorophenyl)Thiazole-4-Carboxamide)


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 1 of PIM1 in Complex with CPD9 ((R)-5-Amino-N-(3-(4-Aminoazepan-1-Yl)-1H- Pyrazol-4-Yl)-2-(2,6-Difluorophenyl)Thiazole-4-Carboxamide) within 5.0Å range:
probe atom residue distance (Å) B Occ
A:F401

b:57.0
occ:1.00
F21 A:KUY401 0.0 57.0 1.0
C20 A:KUY401 1.3 52.3 1.0
C19 A:KUY401 2.4 51.7 1.0
C15 A:KUY401 2.4 49.6 1.0
S12 A:KUY401 2.8 48.7 1.0
C13 A:KUY401 2.8 49.2 1.0
CD A:ARG122 3.3 57.6 1.0
CG A:ARG122 3.3 57.9 1.0
CG1 A:VAL126 3.4 54.0 1.0
CD1 A:LEU44 3.5 72.4 1.0
C18 A:KUY401 3.6 52.6 1.0
C16 A:KUY401 3.6 51.2 1.0
O A:HOH521 3.9 67.1 1.0
N14 A:KUY401 4.1 49.7 1.0
C17 A:KUY401 4.1 54.3 1.0
CD2 A:LEU44 4.3 60.9 1.0
C11 A:KUY401 4.4 46.5 1.0
CB A:ARG122 4.5 57.8 1.0
CG A:LEU44 4.5 70.0 1.0
CD1 A:LEU174 4.6 55.0 1.0
CB A:VAL126 4.6 54.0 1.0
NE A:ARG122 4.7 58.6 1.0
F22 A:KUY401 4.8 52.0 1.0
O A:PRO123 4.8 67.8 1.0
C10 A:KUY401 4.8 46.1 1.0
CG2 A:VAL126 5.0 54.3 1.0

Fluorine binding site 2 out of 2 in 6no8

Go back to Fluorine Binding Sites List in 6no8
Fluorine binding site 2 out of 2 in the PIM1 in Complex with CPD9 ((R)-5-Amino-N-(3-(4-Aminoazepan-1-Yl)-1H- Pyrazol-4-Yl)-2-(2,6-Difluorophenyl)Thiazole-4-Carboxamide)


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 2 of PIM1 in Complex with CPD9 ((R)-5-Amino-N-(3-(4-Aminoazepan-1-Yl)-1H- Pyrazol-4-Yl)-2-(2,6-Difluorophenyl)Thiazole-4-Carboxamide) within 5.0Å range:
probe atom residue distance (Å) B Occ
A:F401

b:52.0
occ:1.00
F22 A:KUY401 0.0 52.0 1.0
C16 A:KUY401 1.3 51.2 1.0
C17 A:KUY401 2.4 54.3 1.0
C15 A:KUY401 2.4 49.6 1.0
H28 A:KUY401 2.7 60.4 1.0
N14 A:KUY401 2.7 49.7 1.0
C13 A:KUY401 2.9 49.2 1.0
C27 A:KUY401 3.4 50.3 1.0
C29 A:KUY401 3.6 52.5 1.0
C18 A:KUY401 3.6 52.6 1.0
C20 A:KUY401 3.6 52.3 1.0
N34 A:KUY401 3.7 48.3 1.0
C31 A:KUY401 3.8 53.0 1.0
CD2 A:LEU174 3.9 51.5 1.0
CD1 A:ILE185 3.9 40.5 1.0
C10 A:KUY401 4.0 46.1 1.0
C19 A:KUY401 4.1 51.7 1.0
N7 A:KUY401 4.2 46.1 1.0
N24 A:KUY401 4.5 48.0 1.0
CD1 A:LEU174 4.5 55.0 1.0
O A:HOH545 4.6 62.6 1.0
S12 A:KUY401 4.6 48.7 1.0
CG A:LEU174 4.6 51.4 1.0
C8 A:KUY401 4.6 47.0 1.0
F21 A:KUY401 4.8 57.0 1.0
C32 A:KUY401 4.8 50.2 1.0
C26 A:KUY401 4.8 46.1 1.0
C11 A:KUY401 4.9 46.5 1.0
CB A:ASP128 5.0 55.2 1.0

Reference:

J.M.Murray, X.Wang. Optimization of Pan-Pim Kinase Activity and Oral Bioavailability Leading to Diaminopyrazole (Gdc-0339) For the Treatment of Multiple Myeloma To Be Published.
Page generated: Sun Dec 13 13:00:57 2020

Last articles

Zn in 8WB0
Zn in 8WAX
Zn in 8WAU
Zn in 8WAZ
Zn in 8WAY
Zn in 8WAV
Zn in 8WAW
Zn in 8WAT
Zn in 8W7M
Zn in 8WD3
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy